Similarly, Aktepe et al. reported that CD47-positive tumors were independently associated with poorer overall survival after adjustment for clinicopathological variables, further supporting the prognostic relevance of CD47 in CRC [92]. The gene discussed is CD47; the disease is colorectal carcinoma.